Ro52/SSA sensitizes cells to death receptor-induced apoptosis by down-regulating c-FLIP(L)

Cell Biology International

Volumn 36, Issue 5, 2012, Pages 463-468

  Zhang, Jing ^a   Fang, Lei ^a   Zhu, Xuguo ^a   Qiao, Yiting ^a   Yu, Mei ^a   Wang, Lu ^a   Chen, Yuan ^a   Yin, Wu ^a   Hua, Zi Chun ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Caspase 8; Cellular (Fas associated death domain) like interleukin 1 converting enzyme inhibitory protein (c FLIP); Nuclear factor (NF ); Ro52 SSA; Tumour necrosis factor related apoptosis inducing ligand (TRAIL)

Indexed keywords

CASPASE 8; CELL PROTEIN; DEATH RECEPTOR; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMALL INTERFERING RNA; TRIPARTITE MOTIF 21 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTIGEN FUNCTION; APOPTOSIS; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR SENSITIVITY; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NF-KAPPA B; RECEPTORS, DEATH DOMAIN; RIBONUCLEOPROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84862486801     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20110322     Document Type: Article

References (20)

1. Aydin C, Sanlioglu AD, Bisgin A, Yoldas B, Dertsiz L, Karacay B et al. NFκB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL. BMC Cancer 2010;10:584-95
2. Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR et al. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J Virol 2000;74:1513-23
3. Blake DJ, Wetzel SA, Pfau JC. Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophages. Toxicology 2008;246:172-9
4. Cao L, Du P, Jiang SH, Jin GH, Huang QL, Hua ZC. Enhancement of the antitumor properties of TRAIL by its targeted delivery to the tumor neovasculature. Mol Cancer Ther 2008;7:851-61
5. Dong W, Li SF, Jin GH, Sun QM, Ma DY, Hua ZC. Efficient gene transfection into mammalian cells mediated by cross-linked polyethylenimine. Int J Mol Sci 2006;7:1-32
6. Espinosa A, Zhou W, Ek M, Hedlund M, Brauner S, Popovic K et al. The Sjögren's syndrome associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. J Immunol 2006;176:6277-85
7. Higgs R, Gabhann JN, Larbi NB, Breen EP, Fitzgerald KA, Jefferies CA. The E3 ubiquitin ligase Ro52 negatively regulates IFN-c production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. J Immunol 2008;181:1780-6
8. Ishii T, Ohnuma K, Murakami A, Takasawa N, Yamochi T, Iwata S et al. SS-A/Ro52, an autoantigen involved in CD28-mediated IL-2 production. J Immunol 2003;170:3653-61
9. Kim Y, Suh N, Sporn M, Reed JC. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis J Biol Chem 2002;277:22320-9
10. Kong HJ, Anderson DE, Lee CH, Jang MK, Tamura T, Tailor P et al. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol 2007;179:26-30
11. McArthur C, Wang Y, Veno P, Zhang J, Fiorella R. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADPribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factoralpha Arch Oral Bio 2002;47:443-8
12. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 2001;21:5299-305
13. Miranda ME, Tseng CE, Rashbaum W, Ochs RL, Casiano CA, Di Donato F et al. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes J Immunol 1998;161:5061-9
14. Nakken B, Jonsson R, Bolstad AI. Polymorphisms of the Ro52 gene associated with anti-Ro 52-kd autoantibodies in patients with primary Sjögren's syndrome. Arthritis Rheum 2001;44:638-6
15. Ohlsson M, Jonsson R, Brokstad KA. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjögren's syndrome. Scand J Immunol 2002;56:456-69
16. Rhodes DA, Ihrke G, Reinicke AT, Malcherek G, Towey M, Isenberg DA et al. The 52000 MW Ro/SS-A autoantigen in Sjögren's syndrome/ systemic lupus erythematosus (Ro52) is an interferon-gamma inducible tripartite motif protein associated with membrane proximal structures. Immunology 2002;106:246-56
17. Safa AR, Day TW, Wu CH. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Curr Cancer Drug Targets 2008;8:37-46
18. Wada K, Kamitani T. Autoantigen Ro52 is an E3 ubiquitin ligase Biochem Biophys Res Commun 2006;339:415-21
19. Wada K, Niida M, Tanaka M, Kamitani T. Ro52-mediated monoubiquitination of IKκB downregulates NF-κB signaling J Biochem 2009;146:821-32
20. Yoshimi R, Chang TH, Wang H, Atsumi T, Morse HC III, Ozato K. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-κB-dependent cytokine expression infibroblasts. J Immunol 2009;182:7527-38